Edition:
United States

People: Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

23.36USD
24 Apr 2019
Change (% chg)

-- (--)
Prev Close
$23.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
172,008
52-wk High
$26.75
52-wk Low
$5.58

Cohen, Fred 

Dr. Fred E. Cohen, M.D. Ph.D. is Independent Director of the Company. He is a senior advisor to TPG where he served as a partner and founder of TPG Biotechnology, a life sciences focused investment effort from October 2001 to December 2016. From 1988 through December 2014, Dr. Cohen was an Adjunct Professor of Cellular and Molecular Pharmacology at the University of California, San Francisco. Dr. Cohen currently serves as a director of BioCryst Pharmaceuticals, Inc., CareDx, Inc., Five Prime Therapeutics, Inc., Genomic Health, Inc., Roka Bioscience, Inc. and Tandem Diabetes Care, Inc., and a number of privately held companies. In addition, Dr. Cohen served as a director of Quintiles Transnational Holdings Inc. from May 2007 until November 2015. Dr. Cohen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University, a D.Phil. in Molecular Biophysics from Oxford University, where he was a Rhodes Scholar, and an M.D. from Stanford University.

Basic Compensation

Total Annual Compensation, USD 52,494
Restricted Stock Awards, USD 10,000
Long-Term Incentive Plans, USD --
All Other, USD 38,356
Fiscal Year Total, USD 100,850

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Bonnie Anderson

2,213,130

Christopher Hall

1,084,000

Keith Kennedy

792,685

John Bishop

113,575

Fred Cohen

100,850

Karin Eastham

111,363
As Of  30 Dec 2017